The Bionano Genomics (NASDAQ: BNGO) stock has displayed a certain degree of volatility this week and it could be important for investors to be abreast of the situation.
On Tuesday, the stock declined sharply by as much as 15% even though there was no material news about the company. While that was surprising, the stock made a recovery on Wednesday and went up by as high as 9.50%. Again, there was no specific news regarding Bionano that could have brought about the recovery. In such a situation, it is important to take a look at the nature of the company’s business. The biotech stock has had an impressive run in 2021 despite the volatility this week.
In recent times, the company had also made announcements that spoke about the progress it has made in the field of genetic research. Earlier this week, the Lineagen division at Bionano announced a new publication as well. It might be a stock that could deserve some attention.